Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 03 - 11 entities : Eli lilly and company save search
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-03-11 (Crawled : 13:07) - fda.gov
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.4%
H: 0.14%
C: -1.03%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.11%
H: 0.31%
C: -1.07%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.12%
H: 0.46%
C: -0.24%
SUPN | $30.26 1.04% 1.02% 200K
|
Health Technology
|
| O: 0.12%
H: 3.37%
C: 3.33%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.31%
H: 0.63%
C: 0.08%
OTIC | $0.077
|
Health Technology
|
| O: 1.81%
H: 2.48%
C: 1.42%
OMER | $3.04 -1.62% -1.64% 250K
|
Health Technology
|
| O: 2.46%
H: 1.25%
C: 0.36%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.63%
H: 0.83%
C: -0.66%
BMRN | $91.25 -0.88% -0.89% 1.6M
|
Health Technology
|
| O: 0.28%
H: 1.23%
C: -0.35%
BCRX | News | $4.22 -3.65% -3.79% 4.4M
|
Health Technology
|
| O: 1.62%
H: 0.65%
C: -6.07%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.3%
H: 1.43%
C: 0.22%
Rigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients
Published: 2021-03-11 (Crawled : 13:01) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
RIGL | $1.125 -1.32% -1.33% 6.4M
|
Health Technology
|
| O: 1.28%
H: 6.55%
C: 6.55%
covid phase 2 trial enroll
Dicerna to Host Webinar on DCR-AUD Alcohol Use Disorder Candidate on March 18, 2021
Published: 2021-03-11 (Crawled : 13:00) - biospace.com/
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 0.24%
H: 0.38%
C: -0.04%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
ALNY | $143.8 -1.55% -1.58% 390K
|
Health Technology
|
| O: 2.62%
H: 3.97%
C: 3.45%
alcohol use disorder
Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19
Published: 2021-03-11 (Crawled : 02:00) - globenewswire.com
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.67%
H: 0.96%
C: 0.54%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
VIR | $8.04 -1.11% -1.12% 770K
|
Health Technology
|
| O: 44.57%
H: 0.75%
C: -8.66%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.31%
H: 0.63%
C: 0.08%
covid treatment risk biotech iot
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.